EXPLEO SOLUTIONS LIMITED (EXPLEOSOL) financials

EXPLEO SOLUTIONS LIMITED (EXPLEOSOL) NSE/BSE financials on Fincrux: quarterly results, profit and loss, cash flow, balance sheet, ratios, and shareholding.

Expleo Solutions Ltd is an India-based software service provider primarily delivering software validation and verification services to the BFSI industry worldwide.[1]

Market Cap: ₹1,392Cr.
Current Price: ₹897
Stock P/E: 11.3
ROE: 17.6%
ROCE: 23.0%
Book Value: ₹430
Dividend Yield: 12.3%
52W High / Low: ₹1,179/640

In Jun 2026, EXPLEO SOLUTIONS LIMITED (EXPLEOSOL) reported sales ₹256 Cr and net profit ₹29 Cr.

Annual TTM: sales ₹973 Cr, net profit ₹115 Cr.

Shareholding: Promoters 71.05% (Sep 2026), FIIs 0.16% (Sep 2026), DIIs 0.40% (Sep 2026), Public 28.40% (Sep 2026), No. of Shareholders 32,900% (Sep 2026).

EXPLEOSOL quarterly results (₹ Cr.)
Category	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Sales	259	258	256	221	237	234	247	256
Expenses	220	222	220	197	197	194	208	218
Operating Profit	39	35	36	25	41	40	38	38
OPM %	15%	14%	14%	11%	17%	17%	16%	15%
Other Income	9	2	13	5	11	-9	12	5
Interest	1	1	1	1	1	0	1	1
Depreciation	9	12	8	7	7	7	6	4
Profit before tax	37	24	40	21	44	24	44	38
Tax %	22%	31%	27%	30%	23%	33%	19%	23%
Net Profit	29	17	29	15	34	16	36	29
EPS in Rs	18.88	10.78	18.61	9.52	21.64	10.34	23.06	18.78
Raw PDF	—	—	—	—	—	—	—	—

EXPLEOSOL profit and loss (₹ Cr.)
Category	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
Sales	270	301	743	903	965	1,025	939	973
Expenses	221	236	622	709	825	875	791	816
Operating Profit	50	64	120	194	140	150	148	158
OPM %	18%	21%	16%	22%	15%	15%	16%	16%
Other Income	6	5	5	9	3	20	15	19
Interest	1	1	1	2	3	3	2	3
Depreciation	6	6	19	27	33	39	28	24
Profit before tax	49	63	105	174	108	128	133	150
Tax %	28%	28%	40%	29%	25%	25%	25%	—
Net Profit	35	45	64	123	81	95	100	115
EPS in Rs	34.09	44.15	62.03	120.22	52.26	61.43	64.56	73.82
Dividend Payout %	0%	0%	0%	6%	0%	81%	0%	—

EXPLEOSOL balance sheet (₹ Cr.)
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	11	10	10	16	16	16	16	16
Reserves	96	105	150	333	458	529	547	652
Borrowings	0	0	7	15	26	26	30	8
Other Liabilities	52	68	62	178	135	125	132	119
Total Liabilities	159	184	228	541	635	696	724	794
Fixed Assets	19	26	25	108	140	130	112	72
CWIP	0	0	0	6	6	5	0	0
Investments	4	4	4	4	4	19	3	6
Other Assets	136	154	199	423	485	542	609	716
Total Assets	159	184	228	541	635	696	724	794

EXPLEOSOL cash flows (₹ Cr.)
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from Operating Activity	54	14	37	19	37	46	135	153
Cash from Investing Activity	24	-7	-27	2	-37	-36	21	-13
Cash from Financing Activity	-26	-29	-3	-10	-7	-15	-87	-9
Net Cash Flow	52	-21	7	11	-7	-5	69	130
Free Cash Flow	52	12	32	-6	-5	29	128	150
CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit	160%	53%	87%	38%	41%	61%	116%	128%

EXPLEOSOL shareholding pattern (%)
Category	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Promoters	71.05%	71.05%	71.05%	71.05%	71.05%	71.05%	71.05%	71.05%
FIIs	0.49%	0.33%	0.09%	0.13%	0.32%	0.42%	0.13%	0.16%
DIIs	1.00%	0.91%	0.84%	0.84%	0.07%	0.01%	0.12%	0.40%
Public	27.46%	27.71%	28.03%	28.00%	28.57%	28.53%	28.71%	28.40%
No. of Shareholders	27,530	28,556	28,491	29,017	29,158	29,133	29,683	32,900

EXPLEOSOL key ratios
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	39	87	88	87	89	110	93	93
Inventory Days	—	—	—	—	—	—	—	—
Days Payable	—	—	—	—	—	—	—	—
Cash Conversion Cycle	39	87	88	87	89	110	93	93
Working Capital Days	-13	17	28	40	81	105	90	86
ROCE %	46%	45%	45%	40%	41%	21%	20%	23%

EXPLEOSOLUpdated 18 Oct 2026, 0:37

Expleo Solutions Limited

EXPLEOSOLUpdated 18 Oct 2026, 0:37

Market Cap

₹1,392Cr.

Current Price

₹897

High / Low

₹1,179/640

Stock P/E

11.3

ROE17.6%

ROCE23.0%

Book Value₹430

Face Value₹10.0

Dividend Yield12.3%

About

Expleo Solutions Ltd is an India-based software service provider primarily delivering software validation and verification services to the BFSI industry worldwide.[1]

Quarterly results

Last reported quarters₹ Cr.

Quarter	Sales	Interest	Expenses	Other Income	Depreciation	Profit Before Tax	Tax	Net Profit	EPS (₹)
Jun 2023	225	1	194	1	8	24	22	18	11.88
Sep 2023	234	1	202	1	8	25	24	19	12.15
Dec 2023	250	1	213	9	8	36	17	30	19.56
Mar 2024	255	1	223	1	9	23	42	13	8.67
Jun 2024	252	1	217	1	9	27	23	20	13.16
Sep 2024	259	1	220	9	9	37	22	29	18.88
Dec 2024	258	1	222	2	12	24	31	17	10.78
Mar 2025	256	1	220	13	8	40	27	29	18.61
Jun 2025	221	1	197	5	7	21	30	15	9.52
Sep 2025	237	1	197	11	7	44	23	34	21.64
Dec 2025	234	0	194	-9	7	24	33	16	10.34
Mar 2026	247	1	208	12	6	44	19	36	23.06
Jun 2026	256	1	218	5	4	38	23	29	18.78

Profit & loss

Annual statement₹ Cr.

Year	Sales	Interest	Expenses	Other Income	Depreciation	Profit Before Tax	Tax	Net Profit	EPS (₹)
Mar 2015	214	2	181	2	5	28	34	18	17.52
Mar 2016	264	0	215	5	4	50	36	32	29.95
Mar 2017	260	0	221	1	5	35	35	22	20.96
Mar 2018	271	0	236	13	6	43	35	28	26.15
Mar 2019	283	0	235	5	5	48	35	31	29.35
Mar 2020	270	1	221	6	6	49	28	35	34.09
Mar 2021	301	1	236	5	6	63	28	45	44.15
Mar 2022	743	1	622	5	19	105	40	64	62.03
Mar 2023	903	2	709	9	27	174	29	123	120.22
Mar 2024	965	3	825	3	33	108	25	81	52.26
Mar 2025	1025	3	875	20	39	128	25	95	61.43
Mar 2026	939	2	791	15	28	133	25	100	64.56
TTM	973	3	816	19	24	150	—	115	73.82

Shareholding pattern

As of Sep 2026%

Holder	Share
Promoters	71.05%
FIIs	0.16%
DIIs	0.4%
Public	28.4%

Shareholding trend

Ownership over time%

Quarter	Promoters	FIIs	DIIs	Government	Public
Dec 2023	71.05%	0.03%	3.26%	—	25.67%
Mar 2024	71.05%	0.04%	2.37%	—	26.56%
Jun 2024	71.05%	0.06%	1.83%	—	27.06%
Sep 2024	71.05%	0.21%	1.78%	—	26.96%
Dec 2024	71.05%	0.49%	1%	—	27.46%
Mar 2025	71.05%	0.33%	0.91%	—	27.71%
Jun 2025	71.05%	0.09%	0.84%	—	28.03%
Sep 2025	71.05%	0.13%	0.84%	—	28%
Dec 2025	71.05%	0.32%	0.07%	—	28.57%
Mar 2026	71.05%	0.42%	0.01%	—	28.53%
Jun 2026	71.05%	0.13%	0.12%	—	28.71%
Sep 2026	71.05%	0.16%	0.4%	—	28.4%

Balance sheet

Assets & liabilities₹ Cr.

Period	Equity Capital	Reserves	Borrowings	Other Liabilities	Total Liabilities	Fixed Assets	CWIP	Investments	Other Assets	Total Assets
Mar 2015	11	74	10	49	144	24	1	4	114	144
Mar 2016	11	77	0	69	157	25	0	4	128	157
Mar 2017	11	93	0	42	146	27	0	4	115	146
Mar 2018	11	91	0	52	154	22	0	4	127	154
Mar 2019	11	96	0	52	159	19	0	4	136	159
Mar 2020	10	105	0	68	184	26	0	4	154	184
Mar 2021	10	150	7	62	228	25	0	4	199	228
Mar 2022	16	333	15	178	541	108	6	4	423	541
Mar 2023	16	458	26	135	635	140	6	4	485	635
Mar 2024	16	529	26	125	696	130	5	19	542	696
Mar 2025	16	547	30	132	724	112	0	3	609	724
Mar 2026	16	652	8	119	794	72	0	6	716	794

Cash flows

Operating, investing & financing₹ Cr.

Period	Operating	Investing	Financing	Net cash flow
Mar 2015	28	-6	-11	10
Mar 2016	47	11	-39	19
Mar 2017	14	-14	-31	-31
Mar 2018	55	-17	-31	7
Mar 2019	54	24	-26	52
Mar 2020	14	-7	-29	-21
Mar 2021	37	-27	-3	7
Mar 2022	19	2	-10	11
Mar 2023	37	-37	-7	-7
Mar 2024	46	-36	-15	-5
Mar 2025	135	21	-87	69
Mar 2026	153	-13	-9	130

Key ratios

Historical financial ratios

Category	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	94	48	104	76	39	87	88	87	89	110	93	93
Inventory Days	—	—	—	—	—	—	—	—	—	—	—	—
Days Payable	—	—	—	—	—	—	—	—	—	—	—	—
Cash Conversion Cycle	94	48	104	76	39	87	88	87	89	110	93	93
Working Capital Days	21	-0	52	18	-13	17	28	40	81	105	90	86
ROCE %	29%	55%	36%	41%	46%	45%	45%	40%	41%	21%	20%	23%

Frequently asked questions

Quick answers about this company's financials on Fincrux

What is the market cap of EXPLEO SOLUTIONS LIMITED (EXPLEOSOL)?

The reported market capitalisation for EXPLEO SOLUTIONS LIMITED (EXPLEOSOL) is ₹1,392Cr. on Fincrux. Figures may update with market data and filings.

What is the current share price of EXPLEOSOL?

The current price shown for EXPLEO SOLUTIONS LIMITED (EXPLEOSOL) on Fincrux is ₹897 with a 52-week high/low of ₹1,179/640.

What is the P/E ratio of EXPLEO SOLUTIONS LIMITED (EXPLEOSOL)?

The stock P/E for EXPLEO SOLUTIONS LIMITED (EXPLEOSOL) is 11.3 on Fincrux, with ROE at 17.6% and ROCE at 23.0%.

What were EXPLEOSOL latest quarterly results?

For Jun 2026, EXPLEO SOLUTIONS LIMITED (EXPLEOSOL) reported sales ₹256 Cr and net profit ₹29 Cr (figures in ₹ crore unless noted).

What are EXPLEOSOL annual sales and net profit?

For TTM, EXPLEO SOLUTIONS LIMITED (EXPLEOSOL) shows sales of ₹973 Cr and net profit of ₹115 Cr on the Fincrux profit & loss statement.

Who owns EXPLEO SOLUTIONS LIMITED (EXPLEOSOL)?

Latest shareholding for EXPLEO SOLUTIONS LIMITED (EXPLEOSOL) on Fincrux: Promoters 71.05% (Sep 2026), FIIs 0.16% (Sep 2026), DIIs 0.40% (Sep 2026), Public 28.40% (Sep 2026), No. of Shareholders 32,900% (Sep 2026).

Where can I find EXPLEO SOLUTIONS LIMITED (EXPLEOSOL) financials?

EXPLEO SOLUTIONS LIMITED (EXPLEOSOL) financials on Fincrux include quarterly results, profit and loss, cash flow, balance sheet, key ratios, and shareholding patterns for NSE/BSE research.

Does Fincrux show EXPLEOSOL balance sheet and cash flow?

Yes. The EXPLEO SOLUTIONS LIMITED (EXPLEOSOL) page on Fincrux includes balance sheet, cash flow statements, historical ratios, and ownership trends alongside quarterly and annual results.

Figures in ₹ crore unless noted. Data sourced for research and may lag filings.

Last updated 18 October 2026 at 0:37